Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management
Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2004
|
Schriftenreihe: | Contemporary Hematology
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from the leading medical centers in the United States and Europe critically review the latest scientific advances in our understanding of the molecular genetics and biology of CLL and apply them to its best management. Their comprehensive reviews of the clinical aspects of CLL focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogeneic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several promising new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed. Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care |
Beschreibung: | 1 Online-Ressource (XIV, 421 p) |
ISBN: | 9781592594122 |
DOI: | 10.1007/978-1-59259-412-2 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046146469 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2004 |||| o||u| ||||||eng d | ||
020 | |a 9781592594122 |9 978-1-59259-412-2 | ||
024 | 7 | |a 10.1007/978-1-59259-412-2 |2 doi | |
035 | |a (ZDB-2-SME)978-1-59259-412-2 | ||
035 | |a (OCoLC)1119030345 | ||
035 | |a (DE-599)BVBBV046146469 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.15 |2 23 | |
245 | 1 | 0 | |a Chronic Lymphocytic Leukemia |b Molecular Genetics, Biology, Diagnosis, and Management |c edited by Guy B. Faguet |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2004 | |
300 | |a 1 Online-Ressource (XIV, 421 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Contemporary Hematology | |
520 | |a Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from the leading medical centers in the United States and Europe critically review the latest scientific advances in our understanding of the molecular genetics and biology of CLL and apply them to its best management. Their comprehensive reviews of the clinical aspects of CLL focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogeneic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several promising new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed. Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care | ||
650 | 4 | |a Hematology | |
650 | 4 | |a Cancer Research | |
650 | 4 | |a Hematology | |
650 | 4 | |a Oncology | |
700 | 1 | |a Faguet, Guy B. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781617373558 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781588290991 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781468497922 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59259-412-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526654 | ||
966 | e | |u https://doi.org/10.1007/978-1-59259-412-2 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484502061056 |
---|---|
any_adam_object | |
author2 | Faguet, Guy B. |
author2_role | edt |
author2_variant | g b f gb gbf |
author_facet | Faguet, Guy B. |
building | Verbundindex |
bvnumber | BV046146469 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-59259-412-2 (OCoLC)1119030345 (DE-599)BVBBV046146469 |
dewey-full | 616.15 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.15 |
dewey-search | 616.15 |
dewey-sort | 3616.15 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-59259-412-2 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02782nmm a2200445zc 4500</leader><controlfield tag="001">BV046146469</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2004 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592594122</subfield><subfield code="9">978-1-59259-412-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59259-412-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-59259-412-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119030345</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146469</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chronic Lymphocytic Leukemia</subfield><subfield code="b">Molecular Genetics, Biology, Diagnosis, and Management</subfield><subfield code="c">edited by Guy B. Faguet</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 421 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Contemporary Hematology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from the leading medical centers in the United States and Europe critically review the latest scientific advances in our understanding of the molecular genetics and biology of CLL and apply them to its best management. Their comprehensive reviews of the clinical aspects of CLL focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogeneic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several promising new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed. Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faguet, Guy B.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781617373558</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781588290991</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781468497922</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59259-412-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526654</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59259-412-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046146469 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:30Z |
institution | BVB |
isbn | 9781592594122 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526654 |
oclc_num | 1119030345 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XIV, 421 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2004 |
publishDateSearch | 2004 |
publishDateSort | 2004 |
publisher | Humana Press |
record_format | marc |
series2 | Contemporary Hematology |
spelling | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management edited by Guy B. Faguet Totowa, NJ Humana Press 2004 1 Online-Ressource (XIV, 421 p) txt rdacontent c rdamedia cr rdacarrier Contemporary Hematology Chronic lymphocytic leukemia (CLL) is the second most frequently encountered leukemia in North America and Europe, and the object of considerable research and treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, prominent physicians and researchers from the leading medical centers in the United States and Europe critically review the latest scientific advances in our understanding of the molecular genetics and biology of CLL and apply them to its best management. Their comprehensive reviews of the clinical aspects of CLL focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogeneic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several promising new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed. Cutting-edge and clinically focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management offers today's hematologists and oncologists the opportunity to update their clinical knowledge and sort out the range of available therapies to provide optimal patient care Hematology Cancer Research Oncology Faguet, Guy B. edt Erscheint auch als Druck-Ausgabe 9781617373558 Erscheint auch als Druck-Ausgabe 9781588290991 Erscheint auch als Druck-Ausgabe 9781468497922 https://doi.org/10.1007/978-1-59259-412-2 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management Hematology Cancer Research Oncology |
title | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management |
title_auth | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management |
title_exact_search | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management |
title_full | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management edited by Guy B. Faguet |
title_fullStr | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management edited by Guy B. Faguet |
title_full_unstemmed | Chronic Lymphocytic Leukemia Molecular Genetics, Biology, Diagnosis, and Management edited by Guy B. Faguet |
title_short | Chronic Lymphocytic Leukemia |
title_sort | chronic lymphocytic leukemia molecular genetics biology diagnosis and management |
title_sub | Molecular Genetics, Biology, Diagnosis, and Management |
topic | Hematology Cancer Research Oncology |
topic_facet | Hematology Cancer Research Oncology |
url | https://doi.org/10.1007/978-1-59259-412-2 |
work_keys_str_mv | AT faguetguyb chroniclymphocyticleukemiamoleculargeneticsbiologydiagnosisandmanagement |